Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute of Environmental Health Sciences (NIEHS) |
---|---|
Information provided by: | National Institute of Environmental Health Sciences (NIEHS) |
ClinicalTrials.gov Identifier: | NCT00015015 |
Dichloroacetate (DCA) is a product of water chlorination and a metabolite of certain industrial solvents, thus making it a chemical of environmental concern. However, DCA is also used as an investigational drug for treating various diseases of adults and children, at doses far greater than those to which humans are normally exposed in the environment. Our research involves how DCA is metabolized by healthy adults and by children with a fatal genetic disease, congenital lactic acidosis (CLA) who are treated with DCA.
Condition | Intervention |
---|---|
Lactic Acidosis |
Drug: Dichloroacetate |
Study Type: | Observational |
Study Design: | Screening, Longitudinal, Defined Population, Prospective Study |
Ages Eligible for Study: | 3 Months to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Children with congenital lactic acidosis Healthy adult volunteers
Study ID Numbers: | 7355-CP-001 |
Study First Received: | April 17, 2001 |
Last Updated: | September 1, 2006 |
ClinicalTrials.gov Identifier: | NCT00015015 History of Changes |
Health Authority: | United States: Federal Government |
Dichloroacetate Chlorinated hydrocarbons Genetic disease Toxicology Biotransformation |
Metabolic Diseases Acidosis, Lactic Metabolic Disorder Acidosis |
Metabolic Diseases Acidosis, Lactic Acid-Base Imbalance Acidosis |